Clonal Evolution of Driver Mutations in Patients
Closed Pre-Solicitation Posted
- Solicitation number
- 75N92024Q1060
- Agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
The National Heart Lung and Blood Institute (NHLBI) of the Department of Health and Human Services (HHS) is seeking proposals for research and development in biotechnology related to clonal evolution of driver mutations in patients. The scope of work includes the development of in vitro diagnostic substances, reagents, test kits, and sets. Key objectives include advancing the understanding of clonal evolution and driver mutations. Proposals will be evaluated based on technical approach, qualifications, and past performance. The pre-solicitation notice was posted on August 15, 2024, and proposals are due by August 22, 2024.
This opportunity is not set aside for any specific business category. There are no details provided regarding potential incumbent contractors or award values. The pre-solicitation notice does not specify the quantity of goods or timeline for services.
Notice text
Clonal Evolution of Driver Mutations in Patients
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity